Real-time enrollment status for this hidradenitis suppurativa (hs) clinical trial
Current Status
Recruiting
Checked: September 23, 2026 at 4:06 AM UTC
| NCT Number | NCT07828860 |
| Recruiting Status | Recruiting |
| Condition | Hidradenitis Suppurativa (HS) |
| Phase | PHASE1 |
| Target Enrollment | 25 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Corvus Pharmaceuticals, Inc. |
| Last Updated on CT.gov | September 22, 2026 (Yesterday) |
As of September 23, 2026: Clinical trial NCT07828860 is currently recruiting participants. This phase1 study for hidradenitis suppurativa (hs) is actively seeking new participants at 11 locations across the United States. The study is sponsored by Corvus Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07828860 is actively recruiting participants as of September 23, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07828860 was last updated Yesterday (September 22, 2026). HelloStudys verifies this status automatically.